Plerixafor Impurity 7 (12HCl) CAS CATO-C4X-11337
| CAS No. | CATO-C4X-11337 |
| Molecular Formula | C46H84N12 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a process- or degradation-related impurity, Plerixafor Impurity 7 (12HCl) (CAS CATO-C4X-11337, C46H84N12HCl) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Structurally, Plerixafor Impurity 7 (12HCl) (C46H84N12HCl) contains a nitrogen-containing heterocyclic scaffold, a nitrile group, chlorine substitution. The molecule exhibits a degree of unsaturation (DBE) of 10.0, corresponding to approximately 10 ring(s) or double-bond equivalent(s). With a molecular weight of 841.72 g/mol, it falls into the high-molecular-weight range. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
CATO manufactures Plerixafor Impurity 7 (12HCl) under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C46H84N12 12*HCl |
| Molecular Weight | 841.72 g/mol |
| Purity | >95% |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 12 |
Related Plerixafor Standards
- Plerixafor Impurity N1 (CAS 104395-69-9)
- Plerixafor (CAS 110078-46-1)
- Plerixafor Impurity 47 DiHCl (CAS 117152-72-4 (free base))
- Plerixafor Impurity 45 DiHCl (CAS 117152-73-5 (free base))
- Plerixafor-d (CAS 1246819-87-3)
- Plerixafor Impurity 44 (CAS 1254176-45-8 (free base))
- Plerixafor Impurity 46 (CAS 128495-30-7)
- Plerixafor 8HCl (CAS 155148-31-5)
Recommended Standards
- Levamisole EP Impurity E (CAS 32190-36-6)
- Sunitinib Impurity 20 (CAS 873077-70-4)
- Metformin EP Impurity D (CAS 108-78-1)
- 3-(4-((1,4-Dioxa-8-azaspiro[4.5]Decan-8-yl)methyl)benzoyl)benzonitrile (CAS 898757-61-4)
- 2-(Azocan-1-yl)pyrimidine-5-carbonitrile (CAS 1707586-61-5)
- 6-(Tert-butoxy)pyridin-3-amine (CAS 58155-80-9)
- 2-(Prop-2-yn-1-yl)cyclopentan-1-ol (CAS 1248797-31-0)
- 4-(1-Methyl-1-phenylethyl)phenyl3-pyrrolidinylether (CAS 946760-31-2)
- S-(5-Fluoro-4'-methoxy-[1,1'-biphenyl]-2-yl) dimethylcarbamothioate (CAS 1332589-82-8)
- Semaglutide impurity 108 (CAS CATO-C4X-2226108)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com